PDGFRB and digestive system neoplasm: Previously, PDGFRβ has been shown to be involved in chemo-resistance in glioblastoma70 and fibrosarcomas15, and in EMT in drug-resistant liver tumors71, with antitumor effects of PDGFRβ inhibition10,72.